BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36051340)

  • 21. Is Gadoxetic Acid Disodium (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging an Accurate Diagnostic Method for Hepatocellular Carcinoma? A Systematic Review with Meta-Analysis.
    Yinzhong W; Xiaoxue T; Jinhui T; Pengcheng Y; Xiaoying L; Junqiang L
    Curr Med Imaging; 2022; 18(6):633-647. PubMed ID: 34533447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma: precursor nodules on pre-procedural gadoxetic acid-enhanced liver magnetic resonance imaging.
    Song KD; Rhim H; Lee MW; Kim YS; Kang TW
    Acta Radiol; 2017 Jul; 58(7):778-785. PubMed ID: 27903759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study.
    Ichikawa S; Motosugi U; Morisaka H; Kozaka K; Goshima S; Ichikawa T
    Magn Reson Med Sci; 2021 Mar; 20(1):47-59. PubMed ID: 32101818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
    Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
    AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria.
    Rhee H; Kim MJ; Park YN; Choi JS; Kim KS
    J Magn Reson Imaging; 2012 Feb; 35(2):393-8. PubMed ID: 21990116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
    Kim SS; Kim SH; Song KD; Choi SY; Heo NH
    J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers.
    Orlacchio A; Chegai F; Fabiano S; Merolla S; Funel V; Di Giuliano F; Manuelli M; Tisone G; Francioso S; Angelico M; Palmieri G; Simonetti G
    Radiol Med; 2016 Jul; 121(7):588-96. PubMed ID: 27100719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging.
    Zech CJ; Ba-Ssalamah A; Berg T; Chandarana H; Chau GY; Grazioli L; Kim MJ; Lee JM; Merkle EM; Murakami T; Ricke J; B Sirlin C; Song B; Taouli B; Yoshimitsu K; Koh DM
    Eur Radiol; 2020 Jan; 30(1):370-382. PubMed ID: 31385048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Living Donor Liver Transplant.
    Chen YS; Lim WX; Lin AN; Chen CL; Tsang LL; Yu CY; Hsu HW; Chuang YH; Cheng YF; Ou HY
    Transplant Proc; 2022 Mar; 54(2):386-390. PubMed ID: 35022135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
    Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
    Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma composed of two different histologic types: imaging features on gadoxetic acid-enhanced liver MRI.
    Kim SH; Jeong WK; Kim Y; Kim MY; Kim J; Pyo JY; Oh YH
    Clin Mol Hepatol; 2013 Mar; 19(1):92-6. PubMed ID: 23593616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
    Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
    Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudolesion of the liver observed on gadoxetate disodium-enhanced magnetic resonance imaging obtained shortly after transarterial chemoembolization for hepatocellular carcinoma.
    Shinagawa Y; Sakamoto K; Fujimitsu R; Ida M; Urakawa H; Kora S; Higashihara H; Takano K; Yoshimitsu K
    Jpn J Radiol; 2010 Jul; 28(6):483-8. PubMed ID: 20661702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.
    Chen C; Zhao H; Fu X; Huang L; Tang M; Yan X; Sun S; Jia W; Mao L; Shi J; Chen J; He J; Zhu J; Qiu Y
    Oncotarget; 2017 May; 8(18):29741-29750. PubMed ID: 28392502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma.
    Ariizumi S; Kitagawa K; Kotera Y; Takahashi Y; Katagiri S; Kuwatsuru R; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):575-85. PubMed ID: 21360083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
    Chen CY; Chen J; Xia CC; Huang ZX; Song B
    J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
    Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
    Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.
    Kang HJ; Lee JM; Yoon JH; Han JK
    Korean J Radiol; 2021 Mar; 22(3):354-365. PubMed ID: 33236540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.